Finance Manager

Can you bring the accounting/finance function to the next level?

Visiopharm was founded in 2001 and has since then been characterized by growth. Until now, sales offices (legal entities) have been established in Sweden, the UK, Germany and in North America – and there are more to come. Visiopharm, with its headquarters in Hørsholm, continue its growth strategy, which makes a continuous impact on the financial area/function.

With reference to the CFO, you will become a central part of the finance function in the headquarters. You will take full ownership of the accounting area being responsible for the financial controlling ensuring that the accounting data is valid and the policies/legal legislation are followed. On group level this includes preparation of interim financial statements, consolidation, financial controlling, monthly management reporting incl. cash flow/liquidity, preparation of the annual financial statement, VAT/tax, ad-hoc finance tasks etc. You are supported by a Senior Accountant, who handles invoicing, debtors/creditors within Navision, payroll etc.

Continuing the development as planned requires that the processes within finance are further developed and streamlined across the legal entities. Hence, you will – besides the daily operational tasks – have an overall focus on streamlining processes, procedures and working methods to ensure future scalability within the accounting/financial area.

Independent working – responsible, dynamic and proficient profile

You have probably found your career within an accountancy firm – either as cand.merc.aud. or HD-R. On top of this, you might have gained experience from the accounting/finance function in an international-oriented organization. Hence, you have proven track record within the accounting profession (preparation of balance sheets, P/L statements, cash flow reports, variance analysis, bookkeeping etc.).

You enjoy improving processes and your mind-set is development-oriented.  This goes hand-in-hand with your structured and analytical approach to work, as well as your attention to details and your ability to get the job done in due time. You are able to communicate with all levels of the organization and create a good network and you master English and Danish language on a high level both verbally/written.

Are you ready for the next step in your career in an entrepreneurial business?

The recruitment process is carried out in collaboration with the consulting company Compass Human Resources Group. If you need further information about the position, please contact Research Consultant Lars Nordlund or Partner Anita Blinkenborg at +45 70 20 12 75. All enquiries will be handled with confidentiality.

If interested, please apply as soon as possible via "Apply now". Applications will be processed on an ongoing basis independently of the deadline. Therefore, we ask you to apply as soon as possible in order to make sure your application is taken into consideration.

About Visiopharm

Visiopharm® is a world leader in Augmented Pathology™ solutions. We strive to be at the forefront of defining and driving improvements in digital pathology image analysis for both research and clinical applications.

The newest advancements in artificial intelligence and deep learning further consolidates our platform as the most comprehensive and highly configurable solution for tissue analysis on the market today. The Visiopharm platform is utilized in tissue-based research and diagnostics by leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and diagnostic pathology labs all over the world.

Since 2018 Visiopharm has increased its workforce by more than 20%, with more than 100 employees globally. Visiopharm A/S is headquartered in Medicon Valley (DTU Science Park in Hørsholm, Denmark) and has branch offices in Sweden, the UK, Germany and in North America. Read more at

Deadline for application: As soon as possible
Workplace: Hørsholm
Reference: 2004.061
Company: Visiopharm

Gem job

Compass Human Resources Group A/S
Publiceret: 12. februar 2020